scholarly article | Q13442814 |
P50 | author | Amilton Antunes Barreira | Q55436928 |
Brian G Weinshenker | Q88536678 | ||
P2093 | author name string | H J Kim | |
W Kim | |||
G T Plant | |||
M Matiello | |||
D G Brum | |||
T Adoni | |||
D J Kingsbury | |||
P2860 | cites work | Environmental changes and epidemiology of multiple sclerosis in the French West Indies. | Q51632600 |
Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. | Q51760587 | ||
Neuromyelitis optica | Q54262864 | ||
NMO-IgG and Devic's neuromyelitis optica: a French experience. | Q55239375 | ||
Polymorphisms in the neuromyelitis optica auto-antigen AQP4 and susceptibility to multiple sclerosis | Q60542796 | ||
Neuromyelitis optica (Devic's syndrome) in two sisters | Q70307654 | ||
Familial neuromyelitis optica (Devic's syndrome) with late onset in Japan | Q74047818 | ||
Neuromyelitis optica and multiple sclerosis in sisters | Q79611637 | ||
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis | Q82449168 | ||
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel | Q24646531 | ||
Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica | Q28262258 | ||
Aquaporin-4 autoantibodies in a paraneoplastic context | Q28279854 | ||
Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders | Q28306660 | ||
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis | Q29615952 | ||
The clinical course of neuromyelitis optica (Devic's syndrome). | Q30581870 | ||
The spectrum of neuromyelitis optica | Q31122077 | ||
Revised diagnostic criteria for neuromyelitis optica | Q34529345 | ||
An epidemiological study of neuromyelitis optica in Cuba | Q34947347 | ||
Neuromyelitis optica (Devic's syndrome): no association with the primary mitochondrial DNA mutations found in Leber hereditary optic neuropathy | Q36901269 | ||
The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes | Q37620680 | ||
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica | Q38429895 | ||
Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. | Q39770767 | ||
Is neuromyelitis optica associated with human leukocyte antigen? | Q44965114 | ||
NMO-IgG predicts the outcome of recurrent optic neuritis | Q46701859 | ||
Neuromyelitis optica in a mother and daughter | Q47573572 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 310-315 | |
P577 | publication date | 2010-07-01 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Familial neuromyelitis optica | |
P478 | volume | 75 |
Q84935048 | Anti-aquaporin-4 antibody-positive familial neuromyelitis optica in mother and daughter |
Q24613666 | Aquaporin 4 and neuromyelitis optica |
Q91706750 | Association Between BDNF Val66Met Polymorphism and Optic Neuritis Damage in Neuromyelitis Optica Spectrum Disorder |
Q48186003 | Association of TNFSF4 Polymorphisms with Neuromyelitis Optica Spectrum Disorders in a Chinese Population |
Q30676331 | Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status. |
Q30577078 | Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. |
Q35718428 | Demographic and clinical features of neuromyelitis optica: A review. |
Q57034928 | Detection of aquaporin-4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania |
Q37104209 | Effects of age and sex on aquaporin-4 autoimmunity |
Q89058024 | Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population |
Q47192132 | Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica |
Q27021535 | Molecular pathogenesis of neuromyelitis optica |
Q47639572 | Multiplex family with GAD65-Abs neurologic syndromes |
Q92854273 | Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes |
Q64075567 | Neuromyelitis optica spectrum disorders |
Q38229823 | Neuromyelitis optica spectrum disorders. |
Q35738898 | Neuromyelitis optica: an antibody-mediated disorder of the central nervous system |
Q36911907 | Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies |
Q30785267 | Neuromyelitis optica: clinical features, immunopathogenesis and treatment. |
Q35539641 | New insights into neuromyelitis optica |
Q35187912 | No association between identified multiple sclerosis non-MHC risk loci and neuromyelitis optica |
Q49336386 | Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases |
Q30610471 | Optic neuritis in neuromyelitis optica |
Q36638942 | Orthogonal array formation by human aquaporin-4: examination of neuromyelitis optica-associated aquaporin-4 polymorphisms |
Q38253493 | Overlapping CNS inflammatory diseases: differentiating features of NMO and MS. |
Q88551231 | Pediatric Neuromyelitis Optica Spectrum Disorders |
Q34591273 | Protective environmental factors for neuromyelitis optica |
Q48157363 | STAT4 Polymorphisms are Associated with Neuromyelitis Optica Spectrum Disorders |
Q36255859 | The Fc Receptor-Like 3 Polymorphisms (rs7528684, rs945635, rs3761959 and rs2282284) and The Risk of Neuromyelitis Optica in A Chinese Population |
Q26767391 | The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives |
Q38031816 | The spectrum of neuromyelitis optica (NMO) in childhood |
Q28245749 | Treatment of neuromyelitis optica: state-of-the-art and emerging therapies |
Q33702126 | Update on neuromyelitis optica: natural history and management |
Q35674960 | Variants of Interferon Regulatory Factor 5 are Associated with Neither Neuromyelitis Optica Nor Multiple Sclerosis in the Southeastern Han Chinese Population |
Search more.